[Federal Register Volume 71, Number 62 (Friday, March 31, 2006)]
[Notices]
[Pages 16310-16311]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-3123]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 71 FR 6777, dated February 9, 2006) is amended 
to reflect the reorganization of the Division of Birth Defects and 
Developmental Disabilities, within the National Center on Birth Defects 
and Developmental Disabilities.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    After the mission statement for the Division of Birth Defects and 
Developmental Disabilities (CUBB), insert the following:
    Office of the Director (CUBB1). (1) Manages, directs, and 
coordinates the research agenda and activities of the division; (2) 
provides leadership and guidance on strategic planning, policy, program 
and project priority planning and setting, program management, and 
operations; (3) establishes division goals, objectives, and priorities; 
(4) monitors progress in implementation of projects and achievement of 
objectives; (5) plans, allocates, and monitors resources; (6) provides 
management, administrative, and support services, and coordinates with 
appropriate NCBDDD offices on program and administrative matters; (7) 
provides liaison with other CDC organizations, other governmental 
agencies, international organizations, and other outside groups; (8) 
provides support for internal scientific advisory groups; (9) provides 
scientific leadership and guidance to the division to assure highest 
scientific quality and professional standards; and (10) provides 
coordinative support for CDC's efforts to reduce adverse consequences 
from birth defects, developmental disabilities, and pediatric genetic 
conditions.
    Birth Defects Branch (CUBBB). (1) Designs and conducts 
epidemiologic and genetic research to identify causes and risk factors 
of birth defects; (2) conducts evaluates interventions to improve 
infant and child health by preventing or reducing the adverse 
consequences of birth defects; (3) designs and conducts surveillance of 
selected birth defects to identify rates, trends, and patterns of 
occurrence, and to evaluate the effectiveness of prevention programs; 
(4) disseminates findings of studies to the scientific and public 
health communities, and to the general public; (5) provides technical 
assistance to state and local agencies on surveillance of birth 
defects, epidemiologic research, prevention program design and 
evaluation, and prevention effectiveness research; (6) funds and 
coordinates grant and cooperative agreement programs and other 
extramural activities to improve the knowledge base for the prevention 
of birth defects through surveillance, epidemiologic research, and 
applies research of preventive interventions; (7) coordinates 
activities with other CDC functional units, HHS, other federal 
agencies,and appropriate private organizations regarding research and 
prevention programs for birth defects; (8) works with international 
organizations in developing strategies for the prevention of birth 
defects; and (9) disseminates findings of research through direct 
contact with health authorities, publication and distribution of 
special reports, publication in scientific and technical journals, 
conference presentations, and other appropriate means.
    Prevention Research Branch (CUBBC). (1) Modifies the impact of 
prenatal exposures leading to adverse physical and developmental 
impairments in infants, children, and adults including integrating 
successful prevention programs into social and medical

[[Page 16311]]

environments, and evaluating innovative, effective, and strategic 
health promotion programs; (2) develops, implements, evaluates, and 
disseminates education and communication interventions that lead to the 
prevention of birth defects and developmental disabilities; (3) designs 
and conducts surveillance of preventable birth defects and 
developmental disabilities to identify rates, trends, and patterns of 
occurrence, and to evaluate the effectiveness of prevention programs; 
(4) disseminates findings of epidemiologic studies to the scientific 
and public health communities, and to the general public; (5) conducts 
prevention effectiveness research to evaluate interventions strategies 
for the prevention of birth defects and developmental disabilities; (6) 
identifies and monitors major preconception, prenatal and perinatal 
risks, and protective factors for fetal alcohol spectrum disorders 
(FASD) and other prenatal alcohol-attributable conditions; (7) provides 
technical assistance to state and local agencies on surveillance, 
epidemiologic research, prevention program design and evaluation, and 
prevention effectiveness research; (8) funds and coordinates grant and 
cooperative agreement programs and other extramural activities to 
improve the knowledge base for the prevention of birth defects and 
developmental disabilities through surveillance, epidemiologic 
research, and applies research of preventive interventions; (9) 
coordinates activities with other CDC functional units, HHS, other 
federal agencies and appropriate private organizations regarding 
research and prevention programs for birth defects and developmental 
disabilities; (10) works with international organizations in developing 
strategies for the prevention of birth defects and developmental 
disabilities; and (11) disseminates finding of research through direct 
contact with health authorities, publication and distribution of 
special reports, publication in scientific and technical journals, 
conference presentations, and other appropriate means.
    Developmental Disabilities Branch (CUBBD). (1) Designs and conducts 
surveillance of developmental disabilities to identify rates, trends, 
and patterns of occurrence, and to evaluate the effectiveness of 
prevention programs; (2) conducts epidemiologic studies of 
developmental disabilities to identify causes and risk factors for 
these conditions; (3) disseminates findings of epidemiologic studies to 
the scientific and public health communities and to the general public; 
(4) conducts prevention effectiveness research to evaluate 
interventions strategies for the prevention of developmental 
disabilities; (5) conducts epidemiologic studies to identify and 
describe specific conditions and long-term outcomes of developmental 
disabilities; (6) provides technical assistance to state and local 
agencies on surveillance of developmental disabilities, epidemiologic 
research, prevention program design and evaluation, and prevention 
effectiveness research; (7) funds and coordinates grant and cooperative 
agreement programs and other extramural activities to improve the 
knowledge base for the prevention of developmental disabilities through 
surveillance, epidemiologic research, and applies research of 
preventive interventions; (8) coordinates activities with other CDC 
functional units, HHS, other Federal agencies and appropriate private 
organizations regarding research and prevention programs for 
developmental disabilities; (9) collaborates with international 
organizations in developing strategies for the prevention of 
developmental disabilities; (10) disseminates findings of research 
through direct contact with health authorities, publication and 
distribution of special reports, publication in scientific and 
technical journals, conference presentations, and other appropriate 
means; and (11) provides training in the epidemiology of developmental 
disabilities to professionals throughout the United States and abroad.

    Dated: March 22, 2006.
William H. Gimson,
Chief Operating Officer, Centers for Disease Control and Prevention 
(CDC).
[FR Doc. 06-3123 Filed 3-30-06; 8:45 am]
BILLING CODE 4160-18-M